These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2247381)

  • 1. What's new in the mechanisms of host resistance to Candida albicans infection?
    Ashman RB; Papadimitriou JM
    Pathol Res Pract; 1990 Aug; 186(4):527-34. PubMed ID: 2247381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic analysis of innate immunity in resistance to Candida albicans.
    Tuite A; Mullick A; Gros P
    Genes Immun; 2004 Nov; 5(7):576-87. PubMed ID: 15372070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro immunity of rat peritoneal macrophages to Candida albicans.
    Joshi KR; Joshi H
    Indian J Chest Dis Allied Sci; 2000; 42(4):341-4. PubMed ID: 15597683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Looking into Candida albicans infection, host response, and antifungal strategies.
    Wang Y
    Virulence; 2015; 6(4):307-8. PubMed ID: 25590793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunity to Candida albicans: Th1, Th2 cells and beyond.
    Romani L
    Curr Opin Microbiol; 1999 Aug; 2(4):363-7. PubMed ID: 10458979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of C3H/HE J mice from development of Candida albicans infection by oral administration of Juzen-taiho-to and its component, Ginseng radix: possible roles of macrophages in the host defense mechanisms.
    Akagawa G; Abe S; Tansho S; Uchida K; Yamaguchi H
    Immunopharmacol Immunotoxicol; 1996 Feb; 18(1):73-89. PubMed ID: 8683040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary defense mechanisms against opportunistic fungal pathogens.
    Waldorf AR
    Immunol Ser; 1989; 47():243-71. PubMed ID: 2490078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active and passive immunization against oral Candida albicans infection in a murine model.
    Farah CS; Ashman RB
    Oral Microbiol Immunol; 2005 Dec; 20(6):376-81. PubMed ID: 16238599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage-dependent candidacidal mechanisms in the murine system. Comparison of murine Kupffer cell and peritoneal macrophage candidacidal mechanisms.
    Redmond HP; Shou J; Gallagher HJ; Kelly CJ; Daly JM
    J Immunol; 1993 Apr; 150(8 Pt 1):3427-33. PubMed ID: 8385685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGF-beta is important in determining the in vivo patterns of susceptibility or resistance in mice infected with Candida albicans.
    Spaccapelo R; Romani L; Tonnetti L; Cenci E; Mencacci A; Del Sero G; Tognellini R; Reed SG; Puccetti P; Bistoni F
    J Immunol; 1995 Aug; 155(3):1349-60. PubMed ID: 7636200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candida and candidiasis in HIV-infected patients: where commensalism, opportunistic behavior and frank pathogenicity lose their borders.
    Cassone A; Cauda R
    AIDS; 2012 Jul; 26(12):1457-72. PubMed ID: 22472853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro natural cell-mediated cytotoxicity against Candida albicans: macrophage precursors as effector cells.
    Baccarini M; Bistoni F; Lohmann-Matthes ML
    J Immunol; 1985 Apr; 134(4):2658-65. PubMed ID: 3882833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate versus adaptive immunity in Candida albicans infection.
    Ashman RB; Farah CS; Wanasaengsakul S; Hu Y; Pang G; Clancy RL
    Immunol Cell Biol; 2004 Apr; 82(2):196-204. PubMed ID: 15061774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An integrated model of the recognition of Candida albicans by the innate immune system.
    Netea MG; Brown GD; Kullberg BJ; Gow NA
    Nat Rev Microbiol; 2008 Jan; 6(1):67-78. PubMed ID: 18079743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infection by Candida albicans inhibits apoptosis of human monocytes and monocytic U937 cells.
    Heidenreich S; Otte B; Lang D; Schmidt M
    J Leukoc Biol; 1996 Dec; 60(6):737-43. PubMed ID: 8975876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene targeting demonstrates that inducible nitric oxide synthase is not essential for resistance to oral candidiasis in mice, or for killing of Candida albicans by macrophages in vitro.
    Farah CS; Saunus JM; Hu Y; Kazoullis A; Ashman RB
    Oral Microbiol Immunol; 2009 Feb; 24(1):83-8. PubMed ID: 19121076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catching fire: Candida albicans, macrophages, and pyroptosis.
    Krysan DJ; Sutterwala FS; Wellington M
    PLoS Pathog; 2014 Jun; 10(6):e1004139. PubMed ID: 24967821
    [No Abstract]   [Full Text] [Related]  

  • 19. Candida albicans cell wall glycans, host receptors and responses: elements for a decisive crosstalk.
    Poulain D; Jouault T
    Curr Opin Microbiol; 2004 Aug; 7(4):342-9. PubMed ID: 15358252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic profiling of serologic response to Candida albicans during host-commensal and host-pathogen interactions.
    Pitarch A; Nombela C; Gil C
    Methods Mol Biol; 2009; 470():369-411. PubMed ID: 19089396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.